Big Data and 4P medicine in pathology

Hinzugefügt: 2026-06-02

[00:00:01][music] >> The incorporation of big data in pathology consolidates a structural change [music] in the healthcare model and in the management of biomedical knowledge by enabling the integration, standardization, and interconnection of large volumes of clinical, histological, and molecular data to support decision-making.

[00:00:24]In this sense, the implementation of coordinated strategies [music] that include the standardization of records, interoperability between systems, and homogeneous [music] protocols is essential to maximize its impact.

[00:00:39]Furthermore, the development of so-called 4P [music] medicine participatory, personalized, predictive, and preventive redefines the boundary between health and disease as it makes [music] it possible to intervene even before the clinical manifestation of symptoms through the analysis of genomic profiles and [music] algorithmic models.

[00:01:03]On the other hand, participatory and personalized medicine [music] expands the patient's role in managing their own health, promoting [music] active involvement through digital platforms and e-health communities [music] that generate data suitable for structured analysis.

[00:01:19]In parallel, population medicine complements [music] this individual approach by segmenting groups according to socio-health characteristics [music] and risk levels allowing for the design of specific preventive policies the monitoring [music] of epidemic outbreaks, and the improvement of the effectiveness of clinical trials.

[00:01:41]Consequently, the strategic use of big data not only increases [music] the efficiency of the healthcare system and reduces costs, but also strengthens diagnostic [music] and therapeutic accuracy, consolidating a data-driven care model that integrates the individual and collective dimensions of disease.